Poll: In Light of the New Information Will You Start Recommending HRT for your Menopausal Patients?
In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research.
In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research. According to the International Menopause Society, women needlessly suffer through severe menopause symptoms because of this. While there is a risk with HRT, it is modest with a slight increased risk of stroke, venous thromboembolism, and breast cancer. The benefits to women include an improved quality of life, reduced risk of heart disease, colorectal cancer, dementia and bone fracture. In light of the new information will you start recommending HRT for your menopausal patients?
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Elinzanetant's efficacy for vasomotor symptoms confirmed in phase 3 trial
March 19th 2024Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.
Read More
